期刊文献+

艾司西酞普兰治疗抑郁症对照研究 被引量:18

Control study of escitalopram and maprotiline in treatment of depression
暂未订购
导出
摘要 目的:探讨艾司西酞普兰治疗抑郁症的疗效及安全性。方法:将63名抑郁症患者随机分为两组,分别给予艾司西酞普兰和马普替林治疗,疗程6周。采用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表病情严重程度(CGI-SI)、治疗中出现的症状量表(TESS)评定疗效及不良反应。结果:艾司西酞普兰与马普替林治疗抑郁症疗效相当,但艾司西酞普兰起效更快,不良反应更少。结论:艾司西酞普兰治疗抑郁症安全有效。 Objective: To detect the et-ficacy and side effects of escitalopram in the treatment of depresssion. Method:63 patients with depression were divided into escitalopram group or maprotiline group respectively for 6 weeks. Hamilton depressive scale (HAMD), clinical global impression severity of illness (CGI-SI) and treatment emergant symptom scale (TESS) were used to evaluate the efficacy and side effects before and after the treatment. Results:There was no significant difference in the efficacy between these two groups. Escitalopram took effect more quickly and less side effects than maprotiline. Conclusion: Escitalopram is a safe and effective antidepressant.
出处 《临床精神医学杂志》 2008年第1期49-50,共2页 Journal of Clinical Psychiatry
关键词 艾司西酞普兰 抑郁症 eseitalopram depression
  • 相关文献

参考文献2

二级参考文献9

共引文献31

同被引文献155

引证文献18

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部